Association between the Triglyceride-Glucose Index and Clinical Outcomes in Acute Atherosclerotic Ischaemic Stroke Patients Following Endovascular Thrombectomy: A Retrospective Cohort Study.
Abstract
Background
We aimed to investigate the association between the triglyceride-glucose (TyG) index and unfavourable clinical outcomes in patients with atherosclerotic acute ischaemic stroke (AIS) undergoing endovascular thrombectomy (EVT).
Methods
Patients with AIS who underwent EVT between January 2019 and September 2024 were enrolled. The primary outcome was an unfavourable functional outcome at 3 months (modified Rankin Scale score 3-6); secondary outcomes were symptomatic intracerebral haemorrhage (sICH) and all-cause mortality at 3 months. The TyG index was analysed continuously and in quartiles by logistic regression, restricted cubic splines and receiver operating characteristic curves.
Results
Among 670 patients, 269 (40.1%) had an unfavourable functional outcome at 3 months, 91 (13.6%) died at 3 months for all-cause, and 85 (12.7%) developed sICH. Compared with the lowest quartile, the highest TyG quartile was independently associated with unfavourable functional outcome (adjusted odds ratio [aOR] 1.91, 95% confidence interval [CI] 1.03-3.56) and mortality (aOR 5.15, 95% CI 2.06-12.86). The overall spline association was significant for all endpoints; only mortality was non-linear (P = 0.032), with risk rising above a TyG index of approximately 8.9. Discrimination was modest, with area under the curve (AUC) values of 0.583 for unfavourable functional outcome and 0.612 for mortality. No significant interactions were found across prespecified subgroups, except for blood glucose level.
Conclusion
An elevated TyG index is independently associated with 3-month unfavourable functional outcome, mortality and sICH after EVT, and may aid prognostic risk stratification, although further validation is required based on the existing predictive indicators.